• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导型 PD-1 对激活的树突状细胞存活的负向作用。

Negative role of inducible PD-1 on survival of activated dendritic cells.

机构信息

1.Pohang University of Science & Technology (POSTECH), San 31 Hyoja Dong, Namgu, Pohang, Korea.

出版信息

J Leukoc Biol. 2014 Apr;95(4):621-9. doi: 10.1189/jlb.0813443. Epub 2013 Dec 6.

DOI:10.1189/jlb.0813443
PMID:24319287
Abstract

PD-1 is a well-established negative regulator of T cell responses by inhibiting proliferation and cytokine production of T cells via interaction with its ligands, B7-H1 (PD-L1) and B7-DC (PD-L2), expressed on non-T cells. Recently, PD-1 was found to be expressed in innate cells, including activated DCs, and plays roles in suppressing production of inflammatory cytokines. In this study, we demonstrate that PD-1 KO DCs exhibited prolonged longevity compared with WT DCs in the dLNs after transfer of DCs into hind footpads. Interestingly, upon LPS stimulation, WT DCs increased the expression of PD-1 and started to undergo apoptosis. DCs, in spleen of LPS-injected PD-1 KO mice, were more resistant to LPS-mediated apoptosis in vivo than WT controls. Moreover, treatment of blocking anti-PD-1 mAb during DC maturation resulted in enhanced DC survival, suggesting that PD-1:PD-L interactions are involved in DC apoptosis. As a result, PD-1-deficient DCs augmented T cell responses in terms of antigen-specific IFN-γ production and proliferation of CD4 and CD8 T cells to a greater degree than WT DCs. Moreover, PD-1 KO DCs exhibited increased MAPK1 and CD40-CD40L signaling, suggesting a possible mechanism for enhanced DC survival in the absence of PD-1 expression. Taken together, our findings further extend the function of PD-1, which plays an important role in apoptosis of activated DCs and provides important implications for PD-1-mediated immune regulation.

摘要

PD-1 是一种成熟的 T 细胞反应负调节剂,通过与非 T 细胞上表达的配体 B7-H1(PD-L1)和 B7-DC(PD-L2)相互作用,抑制 T 细胞的增殖和细胞因子产生。最近发现 PD-1 在先天细胞中表达,包括激活的 DC,并在抑制炎症细胞因子产生中发挥作用。在这项研究中,我们证明了与 WT DC 相比,在将 DC 转移到后脚掌后,PD-1 KO DC 在 dLNs 中表现出更长的寿命。有趣的是,在 LPS 刺激下,WT DC 增加了 PD-1 的表达并开始发生凋亡。与 WT 对照相比,在 LPS 注射的 PD-1 KO 小鼠脾脏中的 LPS 处理的 DC 对 LPS 介导的凋亡具有更强的抵抗力。此外,在 DC 成熟过程中用阻断抗 PD-1 mAb 处理导致 DC 存活增加,表明 PD-1:PD-L 相互作用参与了 DC 凋亡。结果,与 WT DC 相比,PD-1 缺陷型 DC 增强了 T 细胞对抗原特异性 IFN-γ 产生和 CD4 和 CD8 T 细胞增殖的反应。此外,PD-1 KO DC 显示出增加的 MAPK1 和 CD40-CD40L 信号,表明在缺乏 PD-1 表达的情况下增强 DC 存活的可能机制。总之,我们的发现进一步扩展了 PD-1 的功能,它在激活的 DC 凋亡中起重要作用,并为 PD-1 介导的免疫调节提供了重要意义。

相似文献

1
Negative role of inducible PD-1 on survival of activated dendritic cells.诱导型 PD-1 对激活的树突状细胞存活的负向作用。
J Leukoc Biol. 2014 Apr;95(4):621-9. doi: 10.1189/jlb.0813443. Epub 2013 Dec 6.
2
Expression of programmed death 1 ligands by murine T cells and APC.小鼠T细胞和抗原呈递细胞程序性死亡1配体的表达
J Immunol. 2002 Nov 15;169(10):5538-45. doi: 10.4049/jimmunol.169.10.5538.
3
Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.阻断树突状细胞上的程序性死亡-1配体可增强T细胞活化和细胞因子产生。
J Immunol. 2003 Feb 1;170(3):1257-66. doi: 10.4049/jimmunol.170.3.1257.
4
Elderly dendritic cells respond to LPS/IFN-γ and CD40L stimulation despite incomplete maturation.老年树突状细胞对 LPS/IFN-γ 和 CD40L 刺激的反应尽管不成熟。
PLoS One. 2018 Apr 13;13(4):e0195313. doi: 10.1371/journal.pone.0195313. eCollection 2018.
5
Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.树突状细胞通过Fas(CD95/APO-1)途径对细胞凋亡具有抗性。
J Immunol. 1999 Nov 15;163(10):5303-11.
6
Dendritic Cells Exposed to Triiodothyronine Deliver Pro-Inflammatory Signals and Amplify IL-17-Driven Immune Responses.暴露于三碘甲状腺原氨酸的树突状细胞传递促炎信号并放大白细胞介素-17驱动的免疫反应。
Cell Physiol Biochem. 2019;52(2):354-367. doi: 10.33594/000000025. Epub 2019 Feb 28.
7
Fine-tuned expression of programmed death 1 ligands in mature dendritic cells stimulated by CD40 ligand is critical for the induction of an efficient tumor specific immune response.在由CD40配体刺激的成熟树突状细胞中,程序性死亡1配体的微调表达对于诱导有效的肿瘤特异性免疫反应至关重要。
Cell Mol Immunol. 2008 Feb;5(1):33-9. doi: 10.1038/cmi.2008.4.
8
High-level expression of B7-H1 molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals.树突状细胞高水平表达B7-H1分子可抑制活化T细胞的功能,并使经过敏原致敏的动物脱敏。
J Leukoc Biol. 2006 Apr;79(4):686-95. doi: 10.1189/jlb.0805436. Epub 2006 Feb 3.
9
Blockade of B7-H1 enhances dendritic cell-mediated T cell response and antiviral immunity in HBV transgenic mice.阻断 B7-H1 增强乙肝转基因小鼠树突状细胞介导的 T 细胞反应和抗病毒免疫。
Vaccine. 2012 Jan 17;30(4):758-66. doi: 10.1016/j.vaccine.2011.11.076. Epub 2011 Nov 29.
10
Programmed death ligand 1 (PD-L1) plays a vital part in DC tolerogenicity induced by IFN-γ.程序性死亡配体 1(PD-L1)在 IFN-γ 诱导的 DC 耐受中起着至关重要的作用。
Int Immunopharmacol. 2021 Oct;99:107978. doi: 10.1016/j.intimp.2021.107978. Epub 2021 Jul 20.

引用本文的文献

1
Immunoadjuvant therapy in the regulation of cell death in sepsis: recent advances and future directions.脓毒症中免疫佐剂疗法对细胞死亡的调控:最新进展与未来方向
Front Immunol. 2024 Dec 10;15:1493214. doi: 10.3389/fimmu.2024.1493214. eCollection 2024.
2
Molecular Determinants for Photodynamic Therapy Resistance and Improved Photosensitizer Delivery in Glioma.用于光动力疗法耐药性的分子决定因素和脑胶质瘤中光敏剂传递的改进。
Int J Mol Sci. 2024 Aug 9;25(16):8708. doi: 10.3390/ijms25168708.
3
Secondary metabolites of mulberry leaves exert anti-lung cancer activity through regulating the PD-L1/PD-1 signaling pathway.
桑叶的次生代谢产物通过调节PD-L1/PD-1信号通路发挥抗肺癌活性。
J Pharm Anal. 2024 Jun;14(6):100926. doi: 10.1016/j.jpha.2023.12.016. Epub 2023 Dec 22.
4
High-dimensional mapping of human CEACAM1 expression on immune cells and association with melanoma drug resistance.人CEACAM1在免疫细胞上的高维映射及其与黑色素瘤耐药性的关联
Commun Med (Lond). 2024 Jul 2;4(1):128. doi: 10.1038/s43856-024-00525-8.
5
High Level of CD8PD-1 Cells in Patients with Chronic Myeloid Leukemia Who Experienced Loss of MMR after Imatinib Discontinuation.伊马替尼停药后出现错配修复缺失的慢性髓性白血病患者中 CD8PD-1 细胞水平较高。
Cells. 2024 Apr 22;13(8):723. doi: 10.3390/cells13080723.
6
Combination treatment of pembrolizumab with DC-CIK cell therapy for advanced hepatocellular carcinoma: A case report.帕博利珠单抗联合DC-CIK细胞疗法治疗晚期肝细胞癌:1例病例报告
Biomedicine (Taipei). 2023 Sep 1;13(3):57-62. doi: 10.37796/2211-8039.1414. eCollection 2023.
7
Immune interactions in pembrolizumab (PD-1 inhibitor) cancer therapy and cardiovascular complications.免疫相互作用在派姆单抗(PD-1 抑制剂)癌症治疗和心血管并发症中的作用。
Am J Physiol Heart Circ Physiol. 2023 Oct 1;325(4):H751-H767. doi: 10.1152/ajpheart.00378.2023. Epub 2023 Aug 18.
8
Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1.鉴定表达功能性程序性死亡受体-1 的新型脐血 NK 细胞亚群。
Front Immunol. 2023 Jun 22;14:1183215. doi: 10.3389/fimmu.2023.1183215. eCollection 2023.
9
Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma.抗 PD-L1 和来那度胺重编程 PD-1+M2 样肿瘤相关巨噬细胞治疗皮肤 T 细胞淋巴瘤。
JCI Insight. 2023 Jul 10;8(13):e163518. doi: 10.1172/jci.insight.163518.
10
Enhanced anti-tumor immunity of vaccine combined with anti-PD-1 antibody in a murine bladder cancer model.疫苗联合抗 PD-1 抗体增强小鼠膀胱癌模型中的抗肿瘤免疫。
Investig Clin Urol. 2023 Jan;64(1):74-81. doi: 10.4111/icu.20220031.